Cooperation between the hepatitis C virus p7 and NS5B proteins enhances virion infectivity

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11523-11533

  Aligeti, Mounavya ^a   Roder, Allison ^a   Horner, Stacy M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; NONSTRUCTURAL PROTEIN 5B; PROTEIN VP7; RNA POLYMERASE; SPHINGOMYELIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN SPHINGOMYELIN; NS-5 PROTEIN, HEPATITIS C VIRUS; P7 PROTEIN, HEPATITIS C VIRUS; RNA DIRECTED RNA POLYMERASE; VIRAL PROTEIN; VIRUS RNA;

ANTIBODY TITER; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC TRANSCRIPTION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; VIRION; VIRUS ASSEMBLY; VIRUS INFECTIVITY; BIOSYNTHESIS; GENETICS; HEPACIVIRUS; HEPATITIS C; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYSIOLOGY; SEQUENCE ANALYSIS; TUMOR CELL LINE; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE, TUMOR; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPID DROPLETS; LIPOPROTEINS, HDL; RNA REPLICASE; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; SPHINGOMYELINS; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84945920554     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01185-15     Document Type: Article

References (59)

1. Lavanchy D. 2011. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17:107-115. http://dx.doi.org/10.1111/j.1469-0691.2010.03432.x.
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. 2013. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333-1342. http://dx.doi.org/10.1002/hep.26141.
3. SeeffLB. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46.
4. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, Mc-Cone J, Nyberg LM, Lee WM, Ghalib RH, SchiffER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS. 2009. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 361:580-593. http://dx.doi.org/10.1056/NEJMoa0808010.
5. Liang TJ, Ghany MG. 2013. Current and future therapies for hepatitis C virus infection. N Engl J Med 368:1907-1917. http://dx.doi.org/10.1056/NEJMra1213651.
6. Murray CL, Rice CM. 2011. Turning hepatitis C into a real virus. Annu Rev Microbiol 65:307-327. http://dx.doi.org/10.1146/annurev-micro-090110-102954.
7. Moradpour D, Penin F, Rice CM. 2007. Replication of hepatitis C virus. Nat Rev Microbiol 5:453-463. http://dx.doi.org/10.1038/nrmicro1645.
8. Lindenbach BD, Rice CM. 2013. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 11:688-700. http://dx.doi.org/10.1038/nrmicro3098.
9. Suzuki T. 2012. Morphogenesis of infectious hepatitis C virus particles. Front Microbiol 3:38. http://dx.doi.org/10.3389/fmicb.2012.00038.
10. Bartenschlager R, Penin F, Lohmann V, Andre P. 2011. Assembly of infectious hepatitis C virus particles. Trends Microbiol 19:95-103. http://dx.doi.org/10.1016/j.tim.2010.11.005.
11. Li Q, Zhang YY, Chiu S, Hu Z, Lan KH, Cha H, Sodroski C, Zhang F, Hsu CS, Thomas E, Liang TJ. 2014. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLoS Pathog 10:e1004163. http://dx.doi.org/10.1371/journal.ppat.1004163.
12. Shulla A, Randall G. 2012. Hepatitis C virus-host interactions, replication, and viral assembly. Curr Opin Virol 2:725-732. http://dx.doi.org/10.1016/j.coviro.2012.09.013.
13. Aizaki H, Morikawa K, Fukasawa M, Hara H, Inoue Y, Tani H, Saito K, Nishijima M, Hanada K, Matsuura Y, Lai MM, Miyamura T, Wakita T, Suzuki T. 2008. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol 82:5715-5724. http://dx.doi.org/10.1128/JVI.02530-07.
14. Merz A, Long G, Hiet MS, Brugger B, Chlanda P, Andre P, Wieland F, Krijnse-Locker J, Bartenschlager R. 2011. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 286:3018-3032. http://dx.doi.org/10.1074/jbc. M110.175018.
15. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791-796. http://dx.doi.org/10.1038/nm1268.
16. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102:9294-9299. http://dx.doi.org/10.1073/pnas.0503596102.
17. Steinmann E, Pietschmann T. 2013. Cell culture systems for hepatitis C virus. Curr Top Microbiol Immunol 369:17-48. http://dx.doi.org/10.1007/978-3-642-27340-7_2.
18. Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouille Y, Dubuisson J, Wakita T, Duverlie G, Wychowski C. 2007. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88:2495-2503. http://dx.doi.org/10.1099/vir.0.82872-0.
19. Kaul A, Woerz I, Meuleman P, Leroux-Roels G, Bartenschlager R. 2007. Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 81:13168-13179. http://dx.doi.org/10.1128/JVI.01362-07.
20. Jiang J, Luo G. 2012. Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus. J Virol 86:8987-8997. http://dx.doi.org/10.1128/JVI.00004-12.
21. Han Q, Xu C, Wu C, Zhu W, Yang R, Chen X. 2009. Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus Res 145:63-73. http://dx.doi.org/10.1016/j.virusres.2009.06.005.
22. Russell RS, Meunier JC, Takikawa S, Faulk K, Engle RE, Bukh J, Purcell RH, Emerson SU. 2008. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci U S A 105:4370-4375. http://dx.doi.org/10.1073/pnas.0800422105.
23. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV. 2006. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80:11082-11093. http://dx.doi.org/10.1128/JVI.01307-06.
24. Liu S, Xiao L, Nelson C, Hagedorn CH. 2012. A cell culture adapted HCVJFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses. PLoS One 7:e44965. http://dx.doi.org/10.1371/journal.pone.0044965.
25. Pokrovskii MV, Bush CO, Beran RK, Robinson MF, Cheng G, Tirunagari N, Fenaux M, Greenstein AE, Zhong W, Delaney WE, IV, Paulson MS. 2011. Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics. J Virol 85:3978-3985. http://dx.doi.org/10.1128/JVI.01760-10.
26. Kim CS, Keum SJ, Jang SK. 2011. Generation of a cell culture-adapted hepatitis C virus with longer half life at physiological temperature. PLoS One 6:e22808. http://dx.doi.org/10.1371/journal.pone.0022808.
27. Yi M, Ma Y, Yates J, Lemon SM. 2007. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81:629-638. http://dx.doi.org/10.1128/JVI.01890-06.
28. Kang JI, Kim JP, Wakita T, Ahn BY. 2009. Cell culture-adaptive mutations in the NS5B gene of hepatitis C virus with delayed replication and reduced cytotoxicity. Virus Res 144:107-116. http://dx.doi.org/10.1016/j.virusres.2009.04.002.
29. Sumpter R, Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689-2699. http://dx.doi.org/10.1128/JVI.79.5.2689-2699.2005.
30. Horner SM, Park HS, Gale M, Jr. 2012. Control of innate immune signaling and membrane targeting by the hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J Virol 86:3112-3120. http://dx.doi.org/10.1128/JVI.06727-11.
31. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, Wakita T. 2006. Cell culture and infection system for hepatitis C virus. Nat Protoc 1:2334-2339. http://dx.doi.org/10.1038/nprot.2006.395.
32. Gastaminza P, Kapadia SB, Chisari FV. 2006. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 80:11074-11081. http://dx.doi.org/10.1128/JVI.01150-06.
33. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM. 2004. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324:450-461. http://dx.doi.org/10.1016/j.virol.2004.03.034.
34. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676-682. http://dx.doi.org/10.1038/nmeth.2019.
35. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014. http://dx.doi.org/10.1128/JVI.76.24.13001-13014.2002.
36. Boson B, Granio O, Bartenschlager R, Cosset FL. 2011. A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly. PLoS Pathog 7:e1002144. http://dx.doi.org/10.1371/journal.ppat.1002144.
37. Vieyres G, Brohm C, Friesland M, Gentzsch J, Wolk B, Roingeard P, Steinmann E, Pietschmann T. 2013. Subcellular localization and func-tion of an epitope-tagged p7 viroporin in hepatitis C virus-producing cells. J Virol 87:1664-1678. http://dx.doi.org/10.1128/JVI.02782-12.
38. Popescu CI, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, Duverlie G, Penin F, Heliot L, Rouille Y, Dubuisson J. 2011. NS2 protein of hepatitis C virus interacts with structural and nonstructural proteins towards virus assembly. PLoS Pathog 7:e1001278. http://dx.doi.org/10.1371/journal.ppat.1001278.
39. Gouklani H, Beyer C, Drummer H, Gowans EJ, Netter HJ, Haqshenas G. 2013. Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production. J Viral Hepat 20:e66-e71. http://dx.doi.org/10.1111/jvh.12004.
40. Gouklani H, Bull RA, Beyer C, Coulibaly F, Gowans EJ, Drummer HE, Netter HJ, White PA, Haqshenas G. 2012. Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. J Virol 86:5080-5088. http://dx.doi.org/10.1128/JVI.07089-11.
41. Gentzsch J, Brohm C, Steinmann E, Friesland M, Menzel N, Vieyres G, Perin PM, Frentzen A, Kaderali L, Pietschmann T. 2013. Hepatitis C virus p7 is critical for capsid assembly and envelopment. PLoS Pathog 9:e1003355. http://dx.doi.org/10.1371/journal.ppat.1003355.
42. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K. 2007. The lipid droplet is an important organelle for hepatitisCvirus production. Nat Cell Biol 9:1089-1097. http://dx.doi.org/10.1038/ncb1631.
43. Sakamoto H, Okamoto K, Aoki M, Kato H, Katsume A, Ohta A, Tsukuda T, Shimma N, Aoki Y, Arisawa M, Kohara M, Sudoh M. 2005. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat Chem Biol 1:333-337. http://dx.doi.org/10.1038/nchembio742.
44. Weng L, Hirata Y, Arai M, Kohara M, Wakita T, Watashi K, Shimotohno K, He Y, Zhong J, Toyoda T. 2010. Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner. J Virol 84:11761-11770. http://dx.doi.org/10.1128/JVI.00638-10.
45. Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T. 2007. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog 3:e103. http://dx.doi.org/10.1371/journal.ppat.0030103.
46. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. 2007. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81:8374-8383. http://dx.doi.org/10.1128/JVI.00690-07.
47. Bentham MJ, Foster TL, McCormick C, Griffin S. 2013. Mutations in hepatitis C virus p7 reduce both the egress and infectivity of assembled particles via impaired proton channel function. J Gen Virol 94:2236-2248. http://dx.doi.org/10.1099/vir.0.054338-0.
48. OuYang B, Xie S, Berardi MJ, Zhao X, Dev J, Yu W, Sun B, Chou JJ. 2013. Unusual architecture of the p7 channel from hepatitis C virus. Nature 498:521-525. http://dx.doi.org/10.1038/nature12283.
49. Li Q, Pene V, Krishnamurthy S, Cha H, Liang TJ. 2013. Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly. Nat Med 19:722-729. http://dx.doi.org/10.1038/nm.3190.
50. Guo Y, Walther TC, Rao M, Stuurman N, Goshima G, Terayama K, Wong JS, Vale RD, Walter P, Farese RV. 2008. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 453:657-661. http://dx.doi.org/10.1038/nature06928.
51. Wilfling F, Thiam AR, Olarte MJ, Wang J, Beck R, Gould TJ, Allgeyer ES, Pincet F, Bewersdorf J, Farese RV, Jr, Walther TC. 2014. Arf1/COPI machinery acts directly on lipid droplets and enables their connection to the ER for protein targeting. eLife 3:e01607. http://dx.doi.org/10.7554/eLife.01607.
52. Blais DR, Lyn RK, Joyce MA, Rouleau Y, Steenbergen R, Barsby N, Zhu LF, Pegoraro AF, Stolow A, Tyrrell DL, Pezacki JP. 2010. Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication. J Biol Chem 285: 25602-25612. http://dx.doi.org/10.1074/jbc. M110.135483.
53. Vasallo C, Gastaminza P. 30 March 2015. Cellular stress responses in hepatitis C virus infection: mastering a two-edged sword. Virus Res http://dx.doi.org/10.1016/j.virusres.2015.03.013.
54. Young BP, Shin JJ, Orij R, Chao JT, Li SC, Guan XL, Khong A, Jan E, Wenk MR, Prinz WA, Smits GJ, Loewen CJ. 2010. Phosphatidic acid is a pH biosensor that links membrane biogenesis to metabolism. Science 329:1085-1088. http://dx.doi.org/10.1126/science.1191026.
55. Atoom AM, Taylor NG, Russell RS. 2014. The elusive function of the hepatitis C virus p7 protein. Virology 462-463:377-387. http://dx.doi.org/10.1016/j.virol.2014.04.018.
56. Jirasko V, Montserret R, Lee JY, Gouttenoire J, Moradpour D, Penin F, Bartenschlager R. 2010. Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLoS Pathog 6:e1001233. http://dx.doi.org/10.1371/journal.ppat.1001233.
57. Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC. 1999. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 6:937-943. http://dx.doi.org/10.1038/13305.
58. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R. 2008. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4:e1000035. http://dx.doi.org/10.1371/journal.ppat.1000035.
59. Guo M, Pei R, Yang Q, Cao H, Wang Y, Wu C, Chen J, Zhou Y, Hu X, Lu M, Chen X. 2015. Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation. J Virol 89:2367-2377. http://dx.doi.org/10.1128/JVI.02982-14.